News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Opinion: How to Use Mobile Apps for Immunohistochemistry
Alexander E. Kalyuzhny | May 25, 2018
This guide for apps comes from personal experience testing various programs aimed to improve productivity or to help with selecting reagents.
Understanding What Makes a Successful Crowdfunding Campaign
Jim Daley | May 1, 2018
Researchers at the Rare Genomics Institute look at how families finance the cost of diagnostic exome sequencing.
Exome Sequencing Helps Crack Rare Disease Diagnosis
Amanda B. Keener | May 1, 2018
Clinical analyses of patients’ gene sequences are helping to provide answers where none were available before.
Extracting Exosomes to Detect Signs of Cancer in Urine
Ruth Williams | Apr 1, 2018
A new device uses anchored nanowires to capture extracellular vesicles from pee for microRNA analysis.
Genetic Screens Provide Clues About Prognosis, Risk of Second Cancer
Shawna Williams | Apr 1, 2018
Mutations in the
gene appear to influence the prognosis and likelihood of future cancers in pediatric leukemia patients.
Infographic: Capturing Exosomes From Fluids
Ruth Williams | Mar 31, 2018
A microfluidic device collects microRNAs for analysis.
First Blood Test for Concussion Approved by FDA
Kerry Grens | Feb 16, 2018
The diagnostic measures two proteins indicative of brain injury.
New CRISPR-Based Tools Flag Genetic Sequences and Log Data
Diana Kwon | Feb 16, 2018
SHERLOCK and DETECTR can identify particular nucleic acid sequences, while CAMERA records events in human and bacterial cells.
Urine Test for TB Yields Results in 12 Hours
Jef Akst | Dec 14, 2017
The new test could improve upon two current methods to diagnose tuberculosis—a skin test or culturing bacteria from saliva, both of which take days.
Medical Labs Sue US Government Over Medicare Fees
Kerry Grens | Dec 12, 2017
The American Clinical Laboratory Association claims that scheduled reimbursements for tests are too low and could put small companies out of business.